People’s Choice, People’s Problems: Pokonut, FemiSafe, and E42.ai on What Indian Consumers Actually Want

The Economic Times One of a Kind Awards 2026 People’s Choice category produced three winners that, read together, say something specific about India’s consumer moment. Pokonut, a Bengaluru-based Ayurvedic personal care brand, took the top spot. FemiSafe, a Kochi-based women’s hygiene startup, was named first runner-up. E42.ai, a Pune-based enterprise AI platform, took second runner-up. These are not the companies commanding the largest funding rounds or the highest valuations in their respective categories — they are the ones that earned a popular vote. That distinction matters. It tells you something about what Indian consumers are actually choosing, which is often a more reliable signal than what investors are funding.

Pokonut — modern Ayurveda for the Indian consumer

Pokonut was founded in 2022 by Suchint Karnatak and Tulika Pant Karnatak in Bengaluru. The brand makes Ayurvedic skincare, haircare, and personal care products — creams, oils, soaps, stretch-mark treatments, foot care, and baby and mother-care products — formulated with natural ingredients and positioned for the modern Indian consumer who wants the health credentials of traditional Ayurveda in contemporary, accessible packaging.

The brand competes in a category that has attracted significant institutional capital — Kapiva has raised over $60 million, The Ayurveda Company has raised $15.81 million, Nat Habit and Inde Wild have both raised meaningful seed and Series A rounds. Pokonut, by contrast, is bootstrapped. It has raised no institutional funding as of August 2026, making its People’s Choice win at a major ET awards platform a notable signal of organic consumer traction built without the marketing budgets that funded competitors deploy.

The Ayurveda personal care market in India is genuinely large and growing — estimated at approximately $24 billion and expanding at a 15% CAGR through 2026. But the category is also crowded, with both well-funded D2C brands and established FMCG players (Himalaya, Dabur, Patanjali) competing for shelf space and consumer attention. Pokonut’s positioning — modern Ayurveda for Indian bodies, with a specific focus on mother-and-baby care, a segment where trust and ingredient transparency matter enormously — gives it a specific consumer niche that is harder for large players to serve credibly than it appears.

The founders’ background is in consumer products — a relevant credential in a category where formulation quality and supply chain relationships are the primary competitive variables. For investors watching the Ayurvedic personal care space, Pokonut represents the kind of bootstrapped, consumer-validated brand that typically becomes interesting at seed stage once revenue is demonstrably growing. The People’s Choice award is the kind of public signal that tends to accelerate those conversations.

FemiSafe — women’s hygiene with a Tier 2 and Tier 3 focus

FemiSafe was founded in 2020 by Noureen Aysha and Naseef Nazar in Kochi — a city that has produced several credible women’s health and consumer startups in recent years. The company makes women’s personal care and hygiene products with a specific mission: to break stigmas around menstruation and intimate health, particularly in India’s Tier 2 and Tier 3 markets where conversations about these topics remain constrained and product access is limited.

Its product range covers menstrual cups, sterilisers, disposable period products, intimate washes, razors, aloe gel, and underarm sweat pads — a broader and more practical portfolio than the single-product strategy many femtech startups launch with. The company claims it has been profitable since its first month of operations — an unusual and credible data point for a consumer brand in a capital-intensive category.

FemiSafe’s funding history across 7 rounds from 16 investors — totalling $1.27 million — tells a story of a company that has raised capital incrementally rather than in large institutional tranches. The investor base includes Kerala Angel Network, Lunar Family Office, BeyondTeQ Ventures from Oman, and Black Pepper Holdings. The March 2025 seed round of ₹3 crore was led by Tom M Joseph of Jain University, who had previously backed the company at pre-seed. The company plans to use that capital to expand into quick commerce (targeting one-third of revenue through Q-commerce channels by end of 2025), strengthen its offline distribution network across India, and eventually enter Southeast Asian markets.

The Tier 2 and Tier 3 focus is FemiSafe’s most distinctive competitive choice. Most femtech brands in India — Nua, Plush, Carmesi — are built primarily for urban, English-speaking consumers who are already comfortable discussing menstrual health openly. FemiSafe’s community-oriented, education-first model is designed for a different and larger consumer segment: women in smaller cities and towns who have never had a trusted product or conversation about menstrual hygiene. That positioning is harder to build, slower to monetise, and more defensible once established than the urban D2C strategy. It is also the positioning that explains a People’s Choice award — these are the consumers who feel most directly served by what FemiSafe is doing.

E42.ai — enterprise AI co-workers, built in Pune since 2012

E42.ai is the oldest and most institutionally funded of the three — founded in 2012 by Animesh Samuel, Sanjeev Menon, and Sanjeev Prabhakaran Nair under the parent company Light Information Systems. It is also the most technically differentiated: a no-code cognitive process automation platform that lets enterprises build and deploy AI co-workers for complex, multi-function tasks across HR, finance, customer service, IT, and marketing — without writing code.

The company’s origin story is unusual. The founders began by building an SMS-based NLP answering engine called ‘Poochh’ — a question-and-answer service that generated 30 million Q&A pairs from 300,000 users. That dataset became the training foundation for the company’s AI and language models, giving it a proprietary data advantage that most enterprise AI platforms built after 2020 simply cannot replicate. In 2018, E42 went to market with NLPBots and onboarded clients including Mahindra Group and Tata Communications. It has since rebranded and repositioned as E42.ai — a broader agentic AI platform where cognitive agents don’t just converse but own and execute business outcomes.

† Note: Total funding figures vary across sources — Tracxn reports $10.5M and PitchBook reports $20.6M. The confirmed Series A of $5.4M from Pavestone Ventures in October 2021 is the only publicly announced round.

E42’s business model is a platform-as-a-service play: enterprises pay to access the no-code platform and build their own AI co-workers, with E42 providing the underlying NLP and cognitive automation infrastructure. The company claims its agents can handle tasks beyond rule-based automation — understanding context, making decisions, and interacting with humans — a claim that puts it in direct competition with global process automation giants like UiPath and Automation Anywhere, but with a specifically Indian and Middle Eastern enterprise clientele where local regulatory knowledge, language capabilities, and pricing models give E42 structural advantages.

The revenue geography is notable: 50% from the US, 30% from India, and 20% from the Middle East. For a company of this stage and funding profile, generating the majority of revenue from the US market is an unusually strong international credential — it suggests the product has passed procurement and compliance standards of American enterprises, which are typically more demanding than Indian or Middle Eastern equivalents. The company is now expanding into Europe and the UK through a partnership with Care By Tech, a UK-based IT solutions provider.

One data point worth flagging for investors: Tracxn records a 32% year-on-year headcount decline to 78 employees as of August 2025. This could reflect deliberate restructuring toward a leaner, more automated delivery model — or it could reflect revenue pressure. Without public financial statements, the interpretation is uncertain.

What the three companies tell us

Pokonut, FemiSafe, and E42.ai are at completely different stages of commercial development — bootstrapped, seed-stage, and Series A respectively — and serve completely different customer types. What connects them is the specific nature of the consumer validation they have each earned.

A People’s Choice award at a major industry platform is not the same as strong unit economics or a fundable revenue trajectory. But it is a signal that real consumers — not investors, not judges, not industry analysts — have decided to vote with their attention and their wallets for what these three companies are building. In a market where founder narratives have become sophisticated and investor decks have become almost indistinguishable, that kind of signal carries its own weight.

For investors paying attention to India’s consumer and enterprise sectors: Pokonut is a bootstrapped brand in a proven category with demonstrated consumer pull and no institutional capital — a classic pre-seed opportunity if the revenue trajectory is there. FemiSafe is a mission-driven femtech company with $1.27 million raised across 7 rounds, early profitability, and a Tier 2/3 distribution focus that most well-funded competitors have not successfully cracked. E42.ai is a 14-year-old enterprise AI platform that has built genuine NLP infrastructure, serves 60+ enterprise clients globally, generates the majority of its revenue from the US, and is profitable — a company that has been building patiently through every AI hype cycle without raising at inflated valuations. All three are worth a closer look.

Sources: Tracxn, PitchBook, YourStory, Femtech Insider, Indian Startup News, Everything Startups, Onmanorama, Premier Alternatives, Inventiva, Economic Times. All figures verified as of August 24, 2026.